Attachment 1 - Performance Work Statement.pdf

PWS FOR BEP DFWP

Part 1 General Information

1. General: This is a non-personal services BPA to provide drug testing services for the Bureau of Engraving and Printing (BEP) in Fort Worth, Texas (WCF) or Washington, DC (DCF). The government shall not exercise any supervision or control over the contract service providers performing the services herein. Such contract service providers shall be accountable solely to the Contractor who, in turn is responsible to the government.

1.1 Description of Services/Introduction: The contractor shall provide all personnel, training, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services necessary to perform Drug Testing as defined in this Performance Work Statement except for those items specified as government furnished property and services. The contractor shall perform to the standards set forth in this BPA. The contractor will be expected to provide services that are seamless in transmitting information and responding to request. The contractor will also have the ability to transmit PDF and PII or other pertinent information encrypted and without any issues.

1.2 Background: On September 15th, 1986: President Ronald Reagan signed Executive Order (E.O.) 12564, establishing the goal of a Drug-Free Federal Workplace. This order made it a condition of employment for all Federal Employees to refrain from using illegal drugs on or off duty. In a letter to all executive branch employees dated October 4, 1986, the President reiterated his goal of ensuring a safe and drug-free workplace for all Federal workers. The following year, Congress passed legislation, Public Law 100-71, designed to establish uniformity among Federal agencies’ drug testing plans, reliable and accurate drug testing, employee access to drug testing records, confidentiality of drug test results, and centralized oversight of the drug testing program. The 2023 Model Plan for a comprehensive drug-free workplace program mandates the components and other key features for Federal agency plans, and the mandatory guidelines for Federal Workplace Drug Testing Programs, which addresses the scientific and technical guidelines to be used by agencies and their laboratories in the drug testing of Federal employees.

1.3 Objectives: The specific objective of this BPA is to coordinate the collection of specimens required to carry out the BEP’s Drug-Free Federal Workplace Program required under E.O.

12564. Such coordination will be in compliance with the scientific and technical guidelines issued by the Department of Health and Human Services (DHHS) and the Office of Personnel Management for Drug-Free Federal Workplace Programs.

1.4 Scope: E.O. 12564 and Public Law 100-71 prohibit any unauthorized use of controlled substances. Drug testing is conducted by analyzing the applicant’s/employee’s urine or saliva specimen. The analysis is performed at laboratories certified and monitored by DHHS. A list of DHHS approved laboratories is published monthly in the Federal Register. Specimens are analyzed for the following: amphetamines (amphetamine, methamphetamine, methylenedioxyamphetamine [MDA], methylenedioxymethamphetamine [MDMA]); cocaine;

marijuana; opiates/opioids (heroin, codeine, hydrocodone, hydromorphone, morphine, oxycodone, oxymorphone); and phencyclidine (PCP), and other substances identified by DHHS or other legal entities in the future. On a case-by-case basis, specimens may be tested for any of the Schedule I or II drugs of the federal Controlled Substances Act. Urine specimen validity tests are used to determine if a specimen exhibits abnormal physical characteristics, causes reactions or responses characteristic of an adulterant during initial or confirmatory drug tests, or contains an unidentified substance that interferes with the confirmatory analysis. Biomarker tests are used to identify specimens that are not consistent with a human specimen (i.e., based on the absence or abnormal concentration of the biomarker).

1.4.1 BEP-employs approximately 1,918 employees (747 located in Texas and 1171 located in Washington, DC) . Random drug-testing requirements extend to approximately 1400 employees (534 in Texas and 784 in Washington, DC) who occupy testing designated positions. To minimize time away from worksite, BEP will provide an on-site drug-testing area for employee collections at each of its facilities. BEP-WCF has a 7 day a week, 24 hour-a-day operation. Drug-testing provisions must accommodate this operational environment. BEP conducts testing for approximately 300 internal/external applicants and tele/remote workers annually. Pre-employment testing for these individuals and BEP Tele/Remote workers needs to be conducted at clinics near (within a 25-mile radius) the applicant/worker’s home or business address. The applicants and tele/remote worker must be given a specific date and time for their appointment and not simply the hours of operation of the clinic that their drug test is to be conducted. The applicant must also be notified by email and phone of the date, time, and location of their appointment as well as being notified that they have 48 hours to take their test or the job offer could be rescinded.

1.5 Period of Performance: The period of performance shall be for a one (1) year base period from the date of the BPA award, and four subsequent 12-month option periods.

1.6 General Information: N/A

1.6.1 Quality Control: Quality Control is the responsibility of the contractor. The contractor is responsible for the delivery of quality services/supplies to the government.

1.6.1.1 The contractor shall develop, implement, and maintain an effective Quality Control System which includes a written Quality Control Plan (QCP). This plan will be submitted to the Contracting Officer and COR within 30 days after contract award. The QCP shall implement standardized procedure/methodology for monitoring and documenting performance to ensure all BPA requirements are met. The contractor’s QCP must contain a systematic approach to monitor operations to ensure acceptable services/products are provided to the government.

The QCP as a minimum shall address; training and education, procedures for scheduling, conducting and documentation of inspection; discrepancy identification and correction;

corrective action procedures to include procedures for addressing Government discovered non-conformance; procedures for root cause analysis to prevent reoccurrence of discrepancies and procedures for collecting and addressing customer feedback/complaints.

1.6.1.2 The contractor shall upon request provide to the Government their quality control documentation. The documentation will address training and education as well as all testing requirements. Additionally, the contractor agrees to submit Quality Control (QC) specimens to the contract lab in accordance with ratios specified by the DHHS Guidelines. QC specimens will be purchased and repackaged to resemble BEP samples. The contractor will report the results to the Designated Employer Representative (DER)/Contracting Officer Representative (COR) monthly.

1.6.2 Quality Assurance: The government shall evaluate the contractor’s performance under this BPA in accordance with the Quality Assurance Plan. This plan is a Government only document Primarily focused on what the Government must do to assure that the contractor has performed in accordance with the requirements of the BPA.

1.6.3 Federal Government Holidays: Contractor is required to perform services on Federal Holidays.

1.6.4 Hours of Operation: The contractor will be available for collections seven (7) days a week twenty-four (24) hours a day. Collections can be made anytime at both facilities/worksites where operations exist on a 24 hour basis. The collectors must live within 25 mile radius of the WCF BEP facility. The collectors for the D.C. facility must reside in the Washington metropolitan area.

1.6.5 Place of Performance:

BEP-WCF

9000 Blue Mound Road Fort Worth, Texas 76131

BEP-DCF

301 14th and C Street SW Washington, DC 20228

1.6.5.1 The contractor agrees to use collection facilities located within a 25-mile radius of the individuals home or business address, this includes new hires BEP Teleworkers/Remote Workers, and other testing when necessary. However, if the contractor is unable to locate an acceptable collection site, the contractor shall make arrangements to travel to a site mutually agreed upon by both parties. In the event that a drug test must occur outside of normal working hours, the contractor will provide an emergency number for DER to use.

1.6.6 Type of Award: Blanket Purchase Agreement (BPA). Firm Fixed Price BPA Calls will be issued against the BPA.

1.6.7 Physical Security: Information pertinent to BEP personnel is protected from unauthorized disclosure under the provisions of the Privacy Act of 1974 (5 U.S.C. 552a). Contractor personnel shall protect information and treat it as strictly confidential and will abide by the security requirements of the BEP. A violation of this paragraph shall be a material violation of this contract. Should the contractor receive or suspect they have learned of sensitive or classified information, the contractor shall identify and report suspicions to the COR. Contractor personnel performing work under this contract shall be subject of background investigations, conducted by BEP’s Personnel Security Office/Branch, prior to the start of work under this contract. Each contractor employee performing under this contract must successfully complete the Government required background check form at the time of the proposal submission and must maintain the level of security required for the life of this contract.

1.6.7.2 BEP will assume the cost of the background investigation. The contractor will be responsible for ensuring that all information and medical records are maintained in a strictly confidential manner and are stored in locked fireproof filing cabinets, or in a secured room that is not accessible to the general public or visitors. All records are subject to the Privacy Act 5 U.S.C. 552a and will be maintained and used with the highest regard for applicant and employee privacy.

1.6.8 Special Qualifications: The contractor shall ensure that collector, Laboratory, and Medical Review Officer (MRO) are duly certified according the DHHS, Substance Abuse and Mental Health Services Administration (SAMHSA), Mandatory Guidelines for Federal Workplace Drug Testing Programs and that any other sub-contracts to implement this BPA conform to the technical specifications of the Mandatory Guidelines.

1.6.9 Post Award Conference/Periodic Progress Meetings: The contractor agrees to attend any post award conference convened by the contracting activity or contract administration office in accordance with Federal Acquisition Regulation Subpart 42.5, Post Award Orientation. The Contracting Officer, COR, and other Government personnel as appropriate, may meet periodically with the contractor to review the contractor’s performance. At these meetings the Contracting Officer will apprise the contractor of how the government views the contractor’s performance and the contractor will apprise the Government of problems, if any being experienced. Appropriate action shall be taken to resolve outstanding issues. These meeting shall be at no additional cost to the government.

1.6.10 Contracting Officer Representative (COR): The COR will be identified by a separate letter by the Contracting Officer (CO). The COR monitors all technical aspects of the BPA and assists in contract administration. The COR is authorized to perform the following functions: assure that the Contractor performs the technical requirements of the BPA; perform inspections necessary in connection with performance; maintain written and oral communications with the Contractor concerning technical aspects of the BPA; issue written interpretations of technical requirements, including government drawings, designs, and specifications; monitor Contractor’s performance and notify both the Contracting Officer and Contractor of any deficiencies; coordinate availability of government furnished property; and provide site entry of Contractor personnel. A letter of designation issued to the COR, a copy of which is sent to the Contractor, states the responsibilities and limitations of the COR, especially regarding changes in cost or price, estimates or changes in delivery dates. The COR is not authorized to change any of the terms and conditions of the resulting order.

1.6.11 Key Personnel: The following personnel are considered key personnel by the government: BPA Manager/Alternate BPA Manager and the MRO. The contractor shall provide a BPA manager who shall be responsible for the performance of the work. The name of this person and an alternate who shall act for the contractor when the manager is absent shall be designated in writing to the Contracting Officer. The BPA Manager or alternate shall have full authority to act for the contractor on all BPA matters relating to the daily operation of this BPA.

The BPA Manager or alternate shall be available between 6:00 a.m. to 6:00 p.m., Monday thru Friday. In the event the BEP Designated Employer Representative needs to schedule an emergency test outside of normal working hours, the contractor must provide an emergency number.

1.6.12 Identification of Contractor Employees: All BPA personnel (to include subcontractors) attending meetings, answering Government telephones, and working in other situations where their Contractor status is not obvious to third parties are required to identify themselves as such to avoid creating an impression in the minds of members of the public that they are Government officials. They must also ensure that all documents or reports produced by Contractors are suitably marked as Contractor products or that Contract participation is appropriately disclosed. All Contractor personnel shall clearly identify themselves as a Contractor and shall be required to wear identification (ID) badges in a visible location on the front of exterior clothing, above the waist, (except when safety or health reasons prevent such placement). ID badges shall be worn at all times when performing work. ID badges shall have an identification picture and shall state the name of the individual and the company they represent. A listing of issued identification cards shall be furnished to the Contracting Officer prior to the BPA performance date and updated as needed to reflect Contractor and Subcontractor personnel changes. Contractor personnel are prohibited from possessing weapons, firearms, or ammunition, on themselves or within their Contractor-owned or privately owned vehicle while on BEP premises.

1.6.13 Supervision of Contractor Employees: The government will not exercise any supervision or control over Contractor or Subcontractor employees while performing work under the BPA.

Such employees shall be accountable solely to the Contractor, not the Government. The Contractor in turn, shall be accountable to the Government for Contractor or Subcontractor employees.

1.6.14 Contractor Travel: Federal Travel Regulations govern all travel under this BPA.

1.6.15 Organizational Conflict of Interest: Contractor and Subcontractor personnel performing work under this BPA may receive, have access to or participate in the development of proprietary or source selection information (e.g., cost or pricing information, budget information, or analyses, specifications, or work statements, etc.) or perform evaluation services which may create a current or subsequent Organizational Conflict of Interests (OCI) as defined in FAR Subpart 9.5. The Contractor shall notify the Contracting Officer immediately whenever it becomes aware that such access or participation may result in any actual or potential OCI and shall promptly submit a plan to the Contracting Officer to avoid or mitigate any such OCI. The Contractor’s mitigation plan will be determined to be acceptable solely at the discretion of the Contracting Officer and in the event the Contracting Officer unilaterally determines that any such OCI cannot be satisfactorily avoided or mitigated, the Contracting Officer may affect other remedies as he or she deems necessary, including prohibiting the Contractor from participation in subsequent contracted requirements which may be affected by the OCI.

Part 2

DEFINITIONS & ACRONYMS

2. Definitions and Acronyms

2.1 DEFINITIONS

2.1.1 APPLICANT. (Internal/External Applicant). An individual who has applied for employment with BEP and who has been tentatively selected for a specific position.

2.1.2 COLLECTOR. The firm or individual, designated to collect specimens for drug analysis.

2.1.3 CONTRACT SPECIALIST. The official Government representative delegated authority by the Contracting Officer to administer a contract or agreement. This individual is normally a member of the appropriate Contracting/Procurement career field and advises on all technical contractual matters.

2.1.4 CONTRACTOR. A supplier or vendor awarded a contract or agreement to provide specific supplies or services to the government.

2.1.5 CONTRACTING OFFICER (CO). A person with authority to enter into, administer, and/or terminate contracts, and make related determinations and findings on behalf of the government. Note: The only individual who can legally bind the government.

2.1.6 CONTRACTING OFFICER’S REPRESENTATIVE (COR). An employee of the U.S. Government appointed by the Contracting Officer to administer the contract or agreement. Such appointment shall be in writing and shall state the scope of the authority and limitations. This individual has authority to provide technical direction to the Contractor as long as that direction is within the scope of the contract or agreement, does not constitute a change, and has no funding implications. This individual does NOT have authority to change the terms and conditions of the contract or agreement.

2.1.7 DEFECTIVE SERVICE. A service output that does not meet the standard of performance associated with the Performance Work Statement.

2.1.8 DELIVERABLE. Anything that can be physically delivered but may include non-manufactured things such as meeting minutes or reports.

2.1.9 DESIGNATED EMPLOYER REPRESENTATIVE (DER). An employee authorized to take immediate action to remove employees from (or have them removed from) safety-sensitive duties and to make required decisions in the testing and evaluation process.

2.1.10 Government-Furnished Property (GFP) or Government Property (GP). Property in the possession of, or directly acquired by, the Government and subsequently made available to the Contractor.

2.1.11 KEY PERSONNEL. Contractor personnel that are evaluated in a source selection process and that may be required to be used in the performance of a contract or agreement by the Key Personnel listed in the PWS. When key personnel are used as an evaluation factor in best value procurement, an offer can be rejected if it does not have a firm commitment from the persons that are listed in the proposal.

2.1.12 MEDICAL REVIEW OFFICER (MRO). A “licensed physician who is responsible for receiving and reviewing laboratory results generated by an employer’s drug testing program and evaluating medical explanations for certain drug test results.” MRO must adhere to the DHHS, SAMHSA, Center for Substance Abuse Prevention, and MRO manual for Federal Agency Workplace Drug Testing Programs.

2.1.13 PHYSICAL SECURITY. Actions that prevent the loss or damage of Government property.

2.1.14 QUALITY ASSURANCE. The government procedures to verify that services being performed by the Contractor are acceptable in accordance with established standards and requirements of this contract or agreement.

2.1.15 QUALITY ASSURANCE SPECIALIST. An official Government representative concerned with matters pertaining to the contract administration process and quality assurance/quality control.

Acts as technical advisor to the Contracting Officer in these areas.

2.1.16 QUALITY ASSURANCE SURVEILANCE PLAN (QASP). An organized written document specifying the surveillance methodology to be used for surveillance of contractor performance.

2.1.17 QUALITY CONTROL. All necessary measures taken by the Contractor to assure that the quality of an end product or service shall meet BPA requirements.

2.1.18 SUBCONTRACTOR. One that enters into a contract or agreement with a prime contractor. The government does not have privy of contract with the subcontractor.

2.1.19 WORK DAY. The number of hours per day the Contractor provides services in accordance with the BPA.

2.1.20 WORK WEEK. Sunday to Sunday, including Federal Holidays.

2.2 ACRONYMS

ACOR Alternate Contracting Officer’s Representative

BEP Bureau of Engraving and Printing

CO Contracting Officer

CONUS Continental United States (excludes Alaska and Hawaii)

COR Contracting Officer Representative

COTS Commercial-Off-the-Shelf

DER Designated Employer Representative

FAR Federal Acquisition Regulation

HIPPA Health Insurance Portability and Accountability Act of 1996

MRO Medical Review Officer

OCI Organizational Conflict of Interest

OCONUS Outside Continental United States (includes Alaska and Hawaii)

ODC Other Direct Costs

PIPO Phase In/Phase Out

POC Point of Contact

PRS Performance Requirements Summary

PWS Performance Work Statement

QA Quality Assurance

QAP Quality Assurance Program

QASP Quality Assurance Surveillance Program

QC Quality Control

QCP Quality Control Plan

TE Technical Exhibit

PART 3

GOVERNMENT FURNISHED ITEMS AND SERVICES

3.1 SERVICES: The Government will assume the cost of the background investigations for contractors and sub-contractors.

3.2 FACILITIES: The Government will provide workspace for the contractor/sub-contractor collector to provide the support outlined in the PWS to include desk space, telephones, and other office supplies (Does not include drug testing supplies).

3.3 EQUIPMENT: The Government will supply all office equipment needed for drug testing.

3.4 MATERIALS: The Government will provide Standard Operating Procedures and Policies for drug testing onsite.

PART 4

CONTRACTOR FURNISHED ITEMS AND SERVICES

4. CONTRACTOR FURNISHED ITEMS AND RESPONSIBILITIES

4.1 General: The Contractor shall furnish all drug testing supplies, drug testing equipment, offsite facilities and services required to perform work under this BPA that are not listed under Part 3 (Government Furnished Items and Services) of this PWS.

4.2 Materials: The Contractor shall furnish Pre-Employment Applicants with Standard Operating Procedures for drug testing and ensure offsite testing facilities have necessary paperwork and supplies to conduct drug testing.

4.3 Equipment and Software:

4.3.1. The contractor will ensure offsite testing facilities have the equipment and capability needed to process electronic Custody Control Forms (eCCF) to support testing.

4.3.2. The contractor shall possess computer software capable of supporting all testing information, to include, the capability to encrypt and transmit all formats of data (ex: PDF) between contractors, BEP employees, and other required persons or agencies.

PART 5

SPECIFIC TASKS

5. SPECIFIC TASKS:

5.1 BASIC SERVICES: The contractor shall provide services for drug testing.

5.2 TASK HEADING

5.2.1. PERFORMANCE WORK ORDER:

5.2.1.1 The contractor agrees to provide drug testing and associated education and training services to BEP under this BPA. Education raining will occur annually and shall include up to 25 participant slots per each session. Approximately 175 participants annually will require training. with the primary focus geared towards supervisors in all areas related to testing, deterrence, and awareness. Drug testing for individuals may occur in any of the following categories:

5.2.1.1.1 Pre-employment

5.2.1.1.2 Random

5.2.1.1.3 Voluntary

5.2.1.1.4 Reasonable Suspicion

5.2.1.1.5 Follow-up

5.2.1.1.6 Accident or Unsafe Practice

5.2.1.1.7 Education and Training

5.2.1.1.7.1 The contractor shall provide comprehensive education and training to designated Bureau of Engraving and Printing (BEP) personnel, focusing on testing rules and regulations within the drug-free federal workplace program. This training is designed to ensure that BEP supervisors are well-informed and prepared to address scenarios related to reasonable suspicion, return-to-duty, and post-accident testing. Training shall encompass core topics including reasonable suspicion, Designated Employer Representative (DER) roles, drugs in the workplace, opioid awareness, and marijuana regulations. The contractor shall offer continuous updates to keep BEP personnel informed of industry changes and evolving compliance requirements.

Training may be delivered in-person (instructor-led), online, or virtually, and the contractor shall maintain a robust Drug Testing Training and E-Learning Portal to support ongoing education and accessibility for BEP staff.

5.2.2 REQUIREMENTS:

5.2.2.1 Collections must be conducted by the contractor at approved locations throughout the continental U.S., and the territories.

5.2.2.2 The contractor will coordinate on behalf of BEP, drug-testing services as necessary for the collection, shipping, analysis of urine/oral fluid specimens, and for the medical review of laboratory results. Such coordination will occur within the requirements specified by DHHS and will include strict procedures to govern the chain-of-custody of specimens.

5.2.2.3 The contractor will provide all personnel, supplies, storage, and shipping for the collection of urine/oral fluid specimens from BEP applicants and employees. Pre-employment testing may occur in virtually every major metropolitan area in the continental U.S. as well as smaller cities and U. S. Territories.

5.2.2.4 The contractor will notify the BEP within forty-eight (48) hours of the results of the test.

The reported results will be available to the DER/COR electronically.

5.2.3 SCHEDULING SPECIFIC TO COLLECTION:

5.2.3.1 DER will coordinate, with the contractor, the collection of samples for the random testing of its employees, applicants, and the other categories specified in 5.2.1.1.

5.2.3.2 The following timeframes will apply.

5.2.3.2.1 Pre-employment testing: DER/COR will contact the Contractor to schedule testing for applicants. Testing will be scheduled within twenty-four (24) business hours of the notification.

Applicants must receive an appointment to test on a specific day/time. The contractor will advise the applicant the test will occur within 48 hours after notification is received and confirmed.

5.2.3.2.2 Random testing: The DER/COR will schedule employees for random drug testing.

Collectors (1 male/1 female) must reside within 25 mile radius of Texas Facility. The collectors for the D.C. facility must reside in the Washington metropolitan area. For teleworking/remote workers selected for random testing the DER/COR will contact the Contractor to schedule an offsite test. The test will be scheduled within twenty-four (24) business hours of the notification.

5.2.3.2.3 Voluntary: Contractor will be notified within twenty-four (24) hours of the test date, time, and location.

5.2.3.2.4 Reasonable suspicion testing: Testing will be conducted within two (2) hours of notification under Direct Observation.

5.2.3.2.5 Follow-up testing: Scheduling will be accomplished within twenty-four (24) hours of notification under direct observation.

5.2.3.2.6 Accident or Unsafe Practice testing: Testing will be conducted within two (2) hours of notification under Direct Observation.

5.2.3.2.7 Re-scheduling: The contractor will re-schedule all applicants. The DER/COR will contact the contractor to reschedule all other types of testing. Scheduling will be accomplished within twenty-four (24) hours after verbal conversation with contractor unless directed by the MRO to test prior to twenty-four (24) hours. Applicants must receive an appointment to test on a specific day/time.

5.2.4 SPECIMEN COLLECTION SITES, SITE SPECIFICATIONS, AND COLLECTION NOTICES:

5.2.4.1 The contractor will utilize only those collection sites which satisfy requirements of DHHS specified in the Urine/Oral Fluid Specimen Handbook for Drug Free Workplace Programs.

5.2.4.2 The contractor will not utilize specimen collection sites not situated within a twenty-five-mile radius of an individuals home or business address without the prior approval of the DER/COR. The contractor will utilize only those sites having qualified collectors.

5.2.4.3 The contractor will notify the DER/COR within two (2) hours if an individual reports for collection without the proper identification or if an individual fails to appear at the authorized time.

5.2.4.4 The contractor will use only those collection sites which are equipped to appropriately secure and temporarily store under refrigeration, collected specimens.

5.2.4.5 The contractor will contact DER/COR to obtain specific instructions and/or authorization if the applicant/employee is unable to provide a specimen of 45 ml (shy bladder). Split specimens will be used to collect the minimum 45 ml volume of urine required for analysis.

5.2.4.6 The contractor will use only those contractors which have an active and documented collector training program (initial and recurring).

5.2.4.7 The collection site will notify the DER/COR prior to a direct observation collection to receive verbal authorization. When approved a same sex collector will directly observe the collection.

5.2.5 COLLECTION CONTROL REQUIREMENTS (AFFIDAVIT):

5.2.5.1 The contractor will, in conjunction with collectors, ensure that urine/oral fluid specimens taken from individuals are properly identified, collected in strict accordance with the scientific and technical guidelines established by the DHHS.

5.2.5.2 Upon being notified by the COR/DER of drug collection problems, due to failure to comply with the PWS the contractor shall research the problem(s) and report to the COR/DER in writing the corrective actions taken within twenty-four (24) hours after the notification.

5.2.6 ANALYSIS:

5.2.6.1 Specimens will be analyzed by a government approved diagnostic information service company that can process eCCF.

5.2.6.2 Any problems with the receipt of the specimen at the laboratory (insufficient urine/oral fluid, leakage, damage to the shipping container, paperwork problems with the chain-of-custody form, etc.) will be brought to the attention of the DER by the contractor within twenty-four (24) hours.

5.2.7 MEDICAL REVIEW OFFICER (MRO):

5.2.7.1 The contractor will provide medical review of laboratory results. The contractor will ensure the MRO is a licensed physician (Doctor of Medicine or Osteopathy) and trained on the DHHS SAMHSA Center for Substance Abuse Prevention, and MRO Manual for Federal Agency Workplace Drug Testing Programs. The MRO shall have knowledge about and clinical experience in controlled substance abuse disorders, detailed knowledge of alternative medical explanations for laboratory positive drug test results, knowledge about issues relating to adulterated and substituted specimens, and knowledge about possible medical causes for specimens reported as having an invalid result.

5.2.7.2 The contractor will ensure the MRO is not an employee or agent of, and has no financial interest in, the laboratory for which the MRO is reviewing drug test results. The MRO shall not derive any financial benefit by having an agency use a specific drug testing laboratory or have an agreement with the laboratory that may be construed as a potential conflict of interest.

5.2.8 REPORTING:

5.2.8.1 The contractor shall provide the DER/COR results, and statistical summary reports on all collections containing specific details on employees tested using an electronic drug test tracking system. The contractor shall provide the BEP with summary reports on all collections containing specific details on employees tested, type of test conducted, specimen ID, full SSN, site location, and cost incurred no later than the 10th of each month following the month during which there was a site collection conducted. Invoices must be submitted in chronological order of date tested and specimen ID number.

5.2.8.2 In the event of a positive drug test result. The contractor will produce a lab report and submit the report to the DER/COR within fourteen (14) days after occurrence.

5.2.9 DISPOSITION OF RESULTS:

5.2.9.1 All test results will be furnished by the contractor directly to the DER/COR with in forty-eight (48) hours after testing is conducted.

5.2.9.2 The contractor will provide the DER/COR with a username and password and provide access to the contractor’s electronic reporting system to retrieve all drug test results.

5.2.9.3 The contractor will ensure the DER/COR receives the employee CCF/eCCF when testing is conducted offsite within forty-eight (48) hours after testing is completed.

5.2.9.4 BEP’s CCF/eCCF form will be revised by the contractor to reflect the DER and the contractors MRO.

5.2.9.5 The contractor will contact the DER/COR verbally in the event there are any positive, adulterated, substituted, invalid, or cancelled drug test results. This notification will be followed up by fax or email. BEP will take appropriate action to handle and retain these results.

5.2.10 ACCESIBILITY OF ELECTRONIC AND INFORMATION TECHNOLOGY:

5.2.10 Each Electronic and Information Technology (EIT) product or service furnished under this agreement will comply with the Electronic and Information Technology Accessibility Standards (36 CFR 1194), which implements section 508 of the Rehabilitation Act of 1973, as amended (29 U.S.C. 794d)

PART 6

APPLICABLE PUBLICATIONS

6. APPLICABLE PUBLICATIONS (CURRENT EDITIONS)

6.1 The Contractor (to include subcontractors) must abide by all applicable regulations, publications, manuals, and local policies and procedures.

6.1.1 Executive Order 12564

6.1.2 Public Law 100-71

6.1.3 Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Mandatory Guidelines for Federal Workplace Drug Testing Programs;

6.1.3 Collection Site Manual for the Collection of Urine Specimens for Federal Agency Workplace Drug Testing Programs Effective February 2024;

6.1.4 Collection Site Checklist for the Collection of Urine Specimens for Federal Agency Workplace Drug Testing Programs Effective February 2024;

6.1.5 Urine Specimen Collection Handbook for Federal Agency Workplace Drug Testing Programs Effective February 2024;

6.1.6 Collection Site Manual for Collection of Oral Fluid Specimens for Federal Agency Workplace Drug Testing Programs Effective October 2023;

6.1.7 Collection Site Checklist for the Collection of Oral Fluid specimens for Federal Agency Workplace Drug Testing Programs Effective October 2023;

6.1.8 Oral Fluid Specimen Collection Handbook for Federal Agency Workplace Drug Testing Programs Effective October 2023;

6.1.9 Medical Review Officer Guidance Manual for Federal Agency Workplace Drug Testing Programs Effective February 2024.

PART 7 – ATTACHMENT/TECHNICAL EXHIBIT LISTING:

Attachment/Technical Exhibit List:

Attachment 1/Technical Exhibit 1 – Performance Requirements Summary

Attachment 2/Technical Exhibit 2 – Deliverables Schedule

TECHNICAL EXHIBIT 1 – PERFORMANCE REQUIREMENTS SUMMARY

The Contractor tasks requirements summarizes the performance objectives that relates directly to mission essential items. The performance threshold briefly describes the minimum acceptable level of work required for each requirement. These thresholds are critical to mission success.

Performance Objective

Standard Performance Threshold

Incentive (Positive or Negative)

The contractor shall notify BEP of the test results in accordance with 5.2.2.4 of the

PWS.

The contractor shall perform all testing timely in accordance with 5.2.3.2 of PWS.

Within two (2) working days the contractor shall notify the DER/COR of the collections analyzed.

The contractor will ensure pre-employment testing, random testing, voluntary testing, follow up testing, and re-scheduling is scheduled within twenty-four (24) hours after government notification is received.

The contractor will ensure reasonable suspicion testing and accident, or unsafe practice testing is scheduled within two

(2) hours after government

100%

Positive or negative assessment in CPARS.

notification is received.

Performance Objective

Standard Performance Threshold

Incentive (positive or negative)

The contractor shall use specimen collection sites in accordance with PWS 5.2.4.

The contractor will notify the government of individuals with improper identification or individuals that fail to appear in accordance with PWS 5.2.4.3.

provide a complete Education and Training program for approximately 175 participants annually in accordance with

PWS 5.2.1.1.7.1

The contractor shall only utilize collection sites that are following guidelines in the Department of Health and Human Services Urine/Saliva Specimen Handbook for Drug Free Workplace Programs.

The contractor shall notify the DER within two (2) hours if a BEP employee or potential employee reports for collection without proper identification or fails to appear at the scheduled time.

notify the DER regarding Training and Education updates affecting the drug testing program. The DER will determine if these updates or any other information should be included in the training program provided by the contractor.

TECHNICAL EXHIBIT 2 – DELIVERABLES

This Technical Exhibit list any reports or documentation that is required as deliverables to include the frequency, number of copies, medium/format and who/where it is to be submitted.

A deliverable is anything that can be physically delivered but may include non-physical things such as meeting minutes.

Deliverable Frequency Number of copies

Medium/Format Submit to

Quality Control Plan as discussed in

PWS 1.6.1.1

Reports as discussed in

PWS 5.2.8

CCF/eCCF

30 days after BPA award.

Monthly Summary reports, if a positive test occurs then the report must be submitted within fourteen

(14) days.

Received within 48 hours.

Electronically

PDF/MS

Word/Email Microsoft Word 2003 (or higher) format.

PDF/MS

Word/Email Microsoft Word 2003 (or higher) format.

Scan (Password protected)

CO/COR

COR/DER

COR/DER